AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 126 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,741,869 | -42.5% | 2,153,898 | 0.0% | 0.02% | -39.5% |
Q2 2023 | $23,886,729 | -18.3% | 2,153,898 | +13.0% | 0.04% | -20.8% |
Q1 2023 | $29,246,677 | +1.3% | 1,905,321 | +46.5% | 0.05% | -5.9% |
Q4 2022 | $28,868,657 | +352.2% | 1,300,976 | +232.8% | 0.05% | +363.6% |
Q3 2022 | $6,384,000 | +11.7% | 390,928 | -0.6% | 0.01% | +10.0% |
Q2 2022 | $5,715,000 | – | 393,341 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |